Ocular medicines in children: the regulatory situation related to clinical research
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2431
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Ocular medicines in children: the regulatory situation related to clinical research ; volume:12 ; number:1 ; day:20 ; month:1 ; year:2012 ; pages:1-13 ; date:12.2012
BMC pediatrics ; 12, Heft 1 (20.1.2012), 1-13, 12.2012
- Urheber
-
Fortinguerra, Filomena
- Beteiligte Personen und Organisationen
-
Clavenna, Antonio
Bonati, Maurizio
SpringerLink (Online service)
- DOI
-
10.1186/1471-2431-12-8
- URN
-
urn:nbn:de:1111-2016081315013
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fortinguerra, Filomena
- Clavenna, Antonio
- Bonati, Maurizio
- SpringerLink (Online service)
Ähnliche Objekte (12)
Is Medicines Parallel Trade "Regulatory Arbitrage'"?
Is medicines parallel trade ‘regulatory arbitrage’?
Regulatory roadmap for nanotechnology based medicines
Regulatory Reform Outcomes and Accelerated Regulatory Pathways for New Prescription Medicines in Australia
Requirements for generic anti-epileptic medicines: a regulatory perspective
Penetrating Eyelid and Ocular Fishhook-Related Injury
Establishment of the African Medicines Agency: progress, challenges and regulatory readiness
International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines
Ocular manifestations of transthyretin-related familial amyloid polyneuropathy
Correction: International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines
Network medicines™
Epimax-Related Ocular Surface Toxicity (EROST): the Glasgow experience
Is Medicines Parallel Trade "Regulatory Arbitrage'"?
Is medicines parallel trade ‘regulatory arbitrage’?
Regulatory roadmap for nanotechnology based medicines
Regulatory Reform Outcomes and Accelerated Regulatory Pathways for New Prescription Medicines in Australia
Requirements for generic anti-epileptic medicines: a regulatory perspective
Penetrating Eyelid and Ocular Fishhook-Related Injury
Establishment of the African Medicines Agency: progress, challenges and regulatory readiness
International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines
Ocular manifestations of transthyretin-related familial amyloid polyneuropathy
Correction: International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines
Network medicines™
Epimax-Related Ocular Surface Toxicity (EROST): the Glasgow experience
Is Medicines Parallel Trade "Regulatory Arbitrage'"?
Is medicines parallel trade ‘regulatory arbitrage’?
Regulatory roadmap for nanotechnology based medicines
Regulatory Reform Outcomes and Accelerated Regulatory Pathways for New Prescription Medicines in Australia
Requirements for generic anti-epileptic medicines: a regulatory perspective
Penetrating Eyelid and Ocular Fishhook-Related Injury
Establishment of the African Medicines Agency: progress, challenges and regulatory readiness
International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines
Ocular manifestations of transthyretin-related familial amyloid polyneuropathy
Correction: International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines
Network medicines™